MBI.V: Summary for MED BIOGENE INC.- Yahoo! Canada Finance

Skip to search.

Yahoo! Canada Finance

Fri May 24, 2013 7:01AM EDT - Canadian Markets open in 2 hrs 29 mins

TSX

0.74% TSX Ventures 0.00%

Streaming

Ticker Tape: On

More On MBI.V

Quotes

Summary
Order Book
Options
Historical Prices

Charts

News & Info

Headlines
Company Events

Company

Profile
Key Statistics
SEC Filings
Competitors
Industry
Components

Analyst Coverage

Analyst Opinion
Analyst Estimates

Ownership

Major Holders
Insider Transactions
Insider Roster

Financials

Med Biogene, Inc. (MBI.V)

-TSXV

0.16 0.01(3.33%) May 23, 3:59PM EDT

Add to Portfolio

Prev Close:	0.15
Open:	0.14
Bid:	0.14
Ask:	0.16
1y Target Est:	N/A
Beta:	N/A
Next Earnings Date:	N/A

Day's Range:	0.13 - 0.16
52wk Range:	0.02 - 0.21
Volume:	831,905
Avg Vol (3m):	604,795
Market Cap:	12.03M
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A)

Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Med BioGene Inc. Comments on Market ActivityMarketwired(Fri May 17)
Med BioGene Inc. Comments on Market ActivityMarketwired(Fri May 17)
Med BioGene Inc. Comments on Market ActivityMarketwired(Fri May 17)
Med BioGene Announces Adoption of Advance Notice PolicyMarketwired(Thu Apr 18)
Med BioGene Announces Adoption of Advance Notice PolicyMarketwired(Thu Apr 18)
Med BioGene Announces Adoption of Advance Notice PolicyMarketwired(Thu Apr 18)
Med BioGene Announces Date of Annual and Special MeetingMarketwired(Mon Apr 15)
Med BioGene Announces Date of Annual and Special MeetingMarketwired(Mon Apr 15)
Med BioGene Announces Date of Annual and Special MeetingMarketwired(Mon Apr 15)
Med BioGene Reports Financial Results for 2012Marketwired(Tue Apr 9)
Med BioGene Reports Financial Results for 2012Marketwired(Tue Apr 9)
Med BioGene Reports Financial Results for 2012Marketwired(Tue Apr 9)
Med BioGene Announces New Marketing Name for Lung Cancer TestMarketwired(Wed Mar 27)
Med BioGene Announces New Marketing Name for Lung Cancer TestMarketwired(Wed Mar 27)
Med BioGene Announces New Marketing Name for Lung Cancer TestMarketwired(Wed Mar 27)

» More Headlines for MBI.V

Press Releases

Med BioGene Inc. Comments on Market ActivityMarketwired(Fri May 17)
Med BioGene Inc. Comments on Market ActivityMarketwired(Fri May 17)
Med BioGene Inc. Comments on Market ActivityMarketwired(Fri May 17)

» More Press Releases for MBI.V

Must Read

Japan's top leaders defend 'Abenomics' economic strategies as roiled markets settleThe Canadian Press(Thu May 23)
Oil falls below $94 on weak economic outlook, lukewarm demandThe Canadian Press(Thu May 23)
Sears reports bigger-than-expected loss for 1st quarterThe Canadian Press(Thu May 23)
Gap's 1st-quarter net income rises 43 per cent on strong sales as turnaround continuesThe Canadian Press(Thu May 23)
Ralph Lauren's 4Q profit rises 35 pct, but posts sales shortfallThe Canadian Press(Thu May 23)

Med Biogene, Inc. (MBI.V)

customize chart

Comparison

Symbol	% Chg	Mkt Cap
MBI.V	3.33%	12.03M
TMO	0.00%	30.76B
WYETH.NS	0.19%	17.73B
WYETH.BO	0.64%	17.71B
A	0.00%	15.78B

» More Competitors

Key Statistics

Forward P/E (1 yr):	N/A
P/S (ttm):	N/A
Ex-Dividend Date:	N/A

» More Key Statistics

Analysts

Annual EPS Est () :	N/A
Quarterly EPS Est () :	N/A
Mean Recommendation*:	N/A
PEG Ratio (5 yr expected):	N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Med BioGene Inc., a life science company, engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. The companys products include LungExpress Dx, a gene expression-based test for early-stage non-... View More

Company Profile | Industry

Toolbox

Copyright © 2009 Yahoo! All rights reserved.

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc. Real-Time quotes provided by BATS Exchange. US Financials data provided by Edgar Online and all other Financials provided by Capital IQ. International historical chart data, daily updates, fundAnalyst estimates data provided by Thomson Financial Network. All data povided by Thomson Financial Network is based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon.